Mino Caira has directed the Centre for Supramolecular Chemistry Research at the University of Cape Town (UCT) since 2005. He retired as Professor of Physical Chemistry in 2014 and was subsequently appointed as a Senior Scholar in the Department of Chemistry at UCT. His expertise is in the area of solid-state chemistry of drug polymorphs and novel multi-component systems containing active pharmaceutical ingredients. He has published over 300 papers in international journals and since 2009 has served on the Editorial Advisory Board of the Journal of Pharmaceutical Sciences.

Research Interest

Crystalline supramolecular systems containing drug molecules and Drug Delivery Systems


 Alain L Fymat is a medical-physical scientist and an educator who was educated at the Universities of Bordeaux and Paris-Sorbonne, France, and the University of California at Los Angeles. He is the current President/CEO and Professor at the International Institute of Medicine & Science. He was formerly Professor of Radiology, Radiological Sciences, Radiation Medicine (Oncology), Critical Care Medicine, and Physics at several U.S. and European Universities. He has extensively published (~350 scholarly publications) and lectured in several national and international academic, professional, governmental and industrial venues. He is a a Board member of several institutions, Honorable Editor of International Journals of “Cancer Prevention & Current Research”, “Nanomedicine Research”, “Nanomedicine and Nanotechnology” “Open Access Journal of Surgery' and Editor of International Journals of” Nanomedicine”, “Nanobiotechnology”, “Tumor Medicine & Prevention”, “Nanomedicine & Nanoscience Research”, “Cancer Therapy and Oncology”, “Cancer Research & Clinical Oncology (Scientific Synergy Journals)” and “Biomedical Journal of Scientific and Technical Research”.

 Research Interest

 His current research interests lie at the interface between science and medicine (precision medicine, nanobiotechnology, nanomedicine, genetics/epigenetics/ecogenetics)., and drug delivery across the blood brain barrier).


Maha Aboul Ela, graduate of Faculty of Pharmacy, University of Alexandria, Egypt. Ph D in Pharmaceutical Sciences (Pharmacognosy) 1991, University of Alexandria-Egypt and Technical University of Berlin-Germany. She had done her Postdoctoral fellowship, from School of Pharmacy, University of London, UK. She is Member of the American Society of Pharmacognosy. She is also Member of the editorial board of many international scientifi c journals. Currently, she is head of department of Pharmaceutical Sciences, Faculty of Pharmacy, Beirut Arab University, Lebanon.She is Expert in QA in Higher Education. Research interest: Phytochemistry, Phytotherapy, discovering new drugs from natural sources and participation in drug development through applying different pharmaceutical approaches, more than 55 publications in the fi eld of phytochemistry, medicinal plants and phytotherapy.

Research Interest

Research interest: Phytochemistry, Phytotherapy, discovering new drugs from natural sources and participation in drug development through applying different pharmaceutical approaches, more than 55 publications in the fi eld of phytochemistry, medicinal plants and phytotherapy.

Mark Feitelson received his Ph.D. in Microbiology and Immunology in 1979 from the UCLA School of Medicine. He was an American Cancer Society postdoctoral fellow at Stanford University from 1980-82 and was then recruited to the Fox Chase Cancer Center by Dr. Baruch Blumberg (Nobel laureate). In 1991, Dr. Feitelson became Associate Professor of Pathology and Cell Biology and head of the Molecular Diagnostics Lab in Microbiology at Thomas Jefferson University. In 2007, Dr. Feitelson moved to Temple University, where he is now Professor of Biology.  His research has been supported by NIH, industry, and foundations for more than 35 years, has more than 140 publications and is presently head of the Professional Science Master’s program in Biotechnology at Temple University. Since 1980, his research interests have encompassed the pathogenesis of chronic hepatitis B infection and development of hepatocellular carcinoma on the cell and molecular levels.  More recently, he co-founded the biotechnology start-up, SFA Therapeutics, which is developing anti-inflammatory and anti-tumor drugs from the gut microbiome.

Shinsuke Ifuku is a full professor of the Graduate School of Engineering, Tottori University, Japan. He graduated from the Kyoto University and received his Ph.D. of agriculture in 2005. Special attention is dedicated to the development of chitin nanofibers. Chitin nanofibers are fine nanofiber extracted from crab shell waste with 10 nm thick. Chitin nanofiber is a homogeneous water dispersion with efficient physical properties and fine nano-morphology. They showed abundant biological properties after skin or oral administrations. He established a venture company, with the name of MARINE NANOFIBER in 2016 to enhance the commercial application of the novel nanomaterial prepared from food waste.

Hiraku Onishi  Education:

Bachelor: University of Tokyo (1980)

Master: University of Tokyo (1982)

Ph. D: Hoshi University (1989)

Academic Position:

Associate Professor at Hoshi University (2002 - )

Visiting Researcher at the University of Texas at Austin (2003 – 2004)

Professor in Hoshi University (2010 - Till date)


Original paper (149), Review (16), Book (16), Patent (8), International Academic Meeting Presentation (34: Plenary lecture (6))

Nitin Chattopadhyay obtained his master’s in chemistry from Calcutta University and Ph.D. from Jadavpur University. As post-doc he worked in Katholieke University Leuven, Belgium and Coimbra University, Portugal. Professor Chattopadhyay is a Fellow of the Indian Academy of Sciences, the National Academy of Sciences India, and West Bengal Academy of Science and Technology. He is the recipient of a Bronze medal from Chemical Research Society of India. He has been in the Editorial Boards of a number of Elsevier Journals. The broad field of his research interest includes photochemistry, biophysical chemistry, surface chemistry, fluorescence sensing, drug delivery, and excretion, etc.             

Prof. Yoshiki Katayama has completed his Ph.D. from Kyushu University and worked in Dojindo laboratories Inc. Then he moved to Kyushu University as an associate professor in 1996 and became a professor in 2003. He is also a division head of Innovation Center of Advanced Medicine and Dean of Graduate School of System Life Sciences in Kyushu University and an Adjunct Professor in Chung Yuan Christian University in Taiwan. He received ”The Chemical Society of Japan Award for Creative Work” in 2016 and Japan Society of Analytical Chemistry Award in 2018. He has published more than 200 papers in reputed journals.